Who should be prioritised for vaccination?
Initially, as coronavirus vaccines and preventative medicines become available for [...]
Cabozantinib plus atezolizumab combination for advanced kidney cancer
In this study, two doses of cabozantinib were tested in [...]
NHS statement about COVID-19 reponse
Please Read here the NHS response to the Prime Minister's [...]
Everolimus and bevacizumab for advanced papillary kidney cancer
In this phase 2 clinical trial, a combination of everolimus [...]
The role of radiation therapy in kidney cancer
Dr Hans Hammers from the University of Texas Southwestern Medical [...]
ENTRATA study of telaglenastat in combination with everolimus in patients with kidney cancer
In this video interview Dr Chung-Han Lee from Memorial Sloan [...]
New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
Cancer52: Access to data for rare and less common cancers
Sharon Kell attending this meeting with Cancer52 members to discuss [...]
Access to Cancer Medicines Coalition
The first Access to Cancer Medicines (ACMC) meeting since December [...]
Cancer52: CEO Meeting
Sharon Kell took Rose Woodward's place at the Cancer52 Chief [...]
